Leon Barnes, MD , Professor, Department of Pathology, University of Pittsburgh Medical Center Editor(s): Peter Fritsch, MD , Chair, Professor, Department of Dermatology, University of Innsbruck, Austria Michael J Wells, MD , Staff Physician, Department of Dermatology, Texas Tech University Health Sciences Center Drore Eisen, MD, DDS , Consulting Staff, Department of Dermatology, Dermatology Research Associates of Cincinnati Joel M Gelfand, MD, MSCE , Assistant Professor, Department of Dermatology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Hospital William D James, MD , Program Director, Vice-Chair, Albert M Kligman Professor, Department of Dermatology, University of Pennsylvania School of Medicine 2010 Update on new melanoma vaccine trials BACKGROUND: Melanoma is the most serious type of skin cancer
Many agents in the pipeline Davies said the next step forward with obesity and diabetes pharmacotherapy is development of dual and triple agonists
Your body might have B12 floating around in your bloodstream, but if it can't get inside the cells where the real work happens, you'll still experience the symptoms of a deficiency
If proven equally effective, they could dramatically expand adoption, especially among patients needle-averse or unwilling to self-inject
